These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 26301970)
21. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus. Wang J; Bu DF; Li T; Zheng R; Zhang BX; Chen XX; Zhu XJ Br J Dermatol; 2005 Sep; 153(3):558-64. PubMed ID: 16120143 [TBL] [Abstract][Full Text] [Related]
22. Detection of anti-BP180NC16a and anti-BP230 autoantibodies in blister fluid of patients with bullous pemphigoid: the first survey in Greece. Patsatsi A; Vyzantiadis TA; Devliotou-Panagiotidou D; Chrysomallis F; Sotiriadis D Clin Exp Dermatol; 2008 Mar; 33(2):183-5. PubMed ID: 18093242 [TBL] [Abstract][Full Text] [Related]
23. Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid. Bernard P; Antonicelli F; Bedane C; Joly P; Le Roux-Villet C; Duvert-Lehembre S; Rousselle P; Prost-Squarcioni C JAMA Dermatol; 2013 May; 149(5):533-40. PubMed ID: 23426192 [TBL] [Abstract][Full Text] [Related]
24. The prognostic role of detection of circulating melanoma cells in the blood. Dutcher JP J Clin Oncol; 2003 Mar; 21(5):757-9. PubMed ID: 12610168 [No Abstract] [Full Text] [Related]
25. Scarring autoimmune bullous disease in a Ugandan patient with autoantibodies to BP180, BP230, and laminin 5. Mulyowa GK; Jaeger G; Sitaru C; Bröcker EB; Zillikens D; Schmidt E J Am Acad Dermatol; 2006 Feb; 54(2 Suppl):S43-6. PubMed ID: 16427991 [TBL] [Abstract][Full Text] [Related]
26. IgE autoantibodies in bullous pemphigoid: supporting role, or leading player? Ujiie H J Dermatol Sci; 2015 Apr; 78(1):5-10. PubMed ID: 25797172 [TBL] [Abstract][Full Text] [Related]
28. Immunoadsorber for specific apheresis of autoantibodies in the treatment of bullous pemphigoid. Mersmann M; Dworschak J; Ebermann K; Komorowski L; Schlumberger W; Stöcker W; Zillikens D; Probst C; Schmidt E Arch Dermatol Res; 2016 Jan; 308(1):31-8. PubMed ID: 26498290 [TBL] [Abstract][Full Text] [Related]
29. A case of pemphigoid gestationis with concurrent IgG antibodies to BP180, BP230 and type VII collagen. Yang B; Wang C; Wu M; Du D; Yan X; Zhou G; Zhang F Australas J Dermatol; 2014 Feb; 55(1):e15-8. PubMed ID: 23082779 [TBL] [Abstract][Full Text] [Related]
30. Unusual bullous pemphigoid without infiltration of inflammatory cells in the skin lesions. Hara H; Makino T; Matsui K; Takegami Y; Koga H; Fukuda S; Ishii N; Hashimoto T; Shimizu T Eur J Dermatol; 2014; 24(4):488-9. PubMed ID: 25178966 [No Abstract] [Full Text] [Related]
31. Bullous pemphigoid-like eruption subsequent to scabies: bullous scabies or bullous pemphigoid? Huang MX; Li ZS; Luo DQ; Lin Q G Ital Dermatol Venereol; 2015 Jun; 150(3):337-9. PubMed ID: 25658439 [No Abstract] [Full Text] [Related]
32. IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses. Feliciani C; Caldarola G; Kneisel A; Podstawa E; Pfütze M; Pfützner W; Hertl M Br J Dermatol; 2009 Aug; 161(2):306-12. PubMed ID: 19485996 [TBL] [Abstract][Full Text] [Related]
33. Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma. Armand-Labit V; Meyer N; Casanova A; Bonnabau H; Platzer V; Tournier E; Sansas B; Verdun S; Thouvenot B; Hilselberger B; Doncescu A; Lamant L; Lacroix-Triki M; Favre G; Pradines A Acta Derm Venereol; 2016 Jan; 96(1):29-34. PubMed ID: 26039581 [TBL] [Abstract][Full Text] [Related]
34. IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis. Horváth B; Niedermeier A; Podstawa E; Müller R; Hunzelmann N; Kárpáti S; Hertl M Exp Dermatol; 2010 Jul; 19(7):648-53. PubMed ID: 20500772 [TBL] [Abstract][Full Text] [Related]
35. BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid? Schmidt T; Sitaru C; Amber K; Hertl M Br J Dermatol; 2014 Aug; 171(2):212-9. PubMed ID: 24601973 [TBL] [Abstract][Full Text] [Related]
36. [Auto-immune bullous diseases autoantibodies (pemphigus, bullous pemphigoid): what the dermatologist must know]. Ingen-Housz-Oro S; Hüe S; Grootenboer-Mignot S; André C Ann Dermatol Venereol; 2013; 140(8-9):563-70. PubMed ID: 24034645 [No Abstract] [Full Text] [Related]
37. Clinical use of p-proteasome in discriminating metastatic melanoma patients: comparative study with LDH, MIA and S100B protein. Henry L; Fabre C; Guiraud I; Bastide S; Fabbro-Peray P; Martinez J; Lavabre-Bertrand T; Meunier L; Stoebner PE Int J Cancer; 2013 Jul; 133(1):142-8. PubMed ID: 23238767 [TBL] [Abstract][Full Text] [Related]
38. Plasma levels of polychlorinated biphenyls and risk of cutaneous malignant melanoma: a preliminary study. Gallagher RP; Macarthur AC; Lee TK; Weber JP; Leblanc A; Mark Elwood J; Borugian M; Abanto Z; Spinelli JJ Int J Cancer; 2011 Apr; 128(8):1872-80. PubMed ID: 20533551 [TBL] [Abstract][Full Text] [Related]
39. Neuronal autoantibodies associated with cognitive impairment in melanoma patients. Bartels F; Strönisch T; Farmer K; Rentzsch K; Kiecker F; Finke C Ann Oncol; 2019 May; 30(5):823-829. PubMed ID: 30840061 [TBL] [Abstract][Full Text] [Related]
40. Prognostic factors of paraneoplastic pemphigus. Leger S; Picard D; Ingen-Housz-Oro S; Arnault JP; Aubin F; Carsuzaa F; Chaumentin G; Chevrant-Breton J; Chosidow O; Crickx B; D'incan M; Dandurand M; Debarbieux S; Delaporte E; Dereure O; Doutre MS; Guillet G; Jullien D; Kupfer I; Lacour JP; Leonard F; Lok C; Machet L; Martin L; Paul C; Pignon JM; Robert C; Thomas L; Weiller PJ; Ferranti V; Gilbert D; Courville P; Houivet E; Benichou J; Joly P Arch Dermatol; 2012 Oct; 148(10):1165-72. PubMed ID: 22801794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]